Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Latest filing published 10 Aug 2023 for IO Biotech, Inc.. Read the official filing
Filing timeline
BuySaleVivo Capital IX, LLC
Insider track record
Disclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Vivo Capital IX, LLC: trading record in brief
Filings by Vivo Capital IX, LLC span 2 companies, the busiest being Tarsus Pharmaceuticals, Inc. and IO Biotech, Inc. Over a trading history stretching from 21 June 2021 to 9 August 2023, the count stands at 6 filings.
The open-market side counts 1 purchase alongside 4 sales for €3.9M. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2023, the count stands at 1 purchase and no sales.
The latest filing, published on 10 August 2023, reports an open-market purchase in IO Biotech, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Vivo Capital IX, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
3,157,894 shares@ €1.7308100.0% of flowCommon StockSEC:0001213900-23-065297:0
Canonical exit: 7 Nov 2023 (T+90)
5,374 shares@ US$12.251.6% of flowCommon StockSEC:0001213900-22-024317:0
41,800 shares@ US$15.1915.5% of flowCommon StockSEC:0001213900-22-024052:0
2,365,545 sharesCommon StockSEC:0001140361-21-037658:0
37,980 shares@ US$29.8024.3% of flowCommon StockSEC:0001213900-21-034310:0
91,620 shares@ US$29.7058.6% of flowCommon StockSEC:0001213900-21-034298:0
6 of 6 declarations
